Search

Hai V Tran

Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )

Most Active Art Unit
2845
Art Unit(s)
2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821
Total Applications
1291
Issued Applications
923
Pending Applications
111
Abandoned Applications
257

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16570642 [patent_doc_number] => 20210009648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => PEPTIDES FOR TREATMENT OF DIABETES [patent_app_type] => utility [patent_app_number] => 17/022526 [patent_app_country] => US [patent_app_date] => 2020-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14508 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17022526 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/022526
PEPTIDES FOR TREATMENT OF DIABETES Sep 15, 2020 Abandoned
Array ( [id] => 16540982 [patent_doc_number] => 20200407395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => CHIRAL PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/011264 [patent_app_country] => US [patent_app_date] => 2020-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21151 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011264 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/011264
CHIRAL PEPTIDES Sep 2, 2020 Abandoned
Array ( [id] => 16525253 [patent_doc_number] => 20200399333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => HISTATINS AND METHOD OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/011273 [patent_app_country] => US [patent_app_date] => 2020-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8539 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011273 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/011273
Histatins and method of use thereof Sep 2, 2020 Issued
Array ( [id] => 16451062 [patent_doc_number] => 20200360488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS [patent_app_type] => utility [patent_app_number] => 16/989225 [patent_app_country] => US [patent_app_date] => 2020-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33612 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989225 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/989225
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS Aug 9, 2020 Abandoned
Array ( [id] => 17996725 [patent_doc_number] => 11497812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-15 [patent_title] => Compositions and methods for inhibiting the activity of LAR family phosphatases [patent_app_type] => utility [patent_app_number] => 16/983879 [patent_app_country] => US [patent_app_date] => 2020-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 20886 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983879 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/983879
Compositions and methods for inhibiting the activity of LAR family phosphatases Aug 2, 2020 Issued
Array ( [id] => 18535905 [patent_doc_number] => 20230240991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => PROTEOPHOSPHOLIPOSOMES HAVING HDL-TYPE VESICLES [patent_app_type] => utility [patent_app_number] => 17/300210 [patent_app_country] => US [patent_app_date] => 2020-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19577 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300210 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/300210
PROTEOPHOSPHOLIPOSOMES HAVING HDL-TYPE VESICLES Jul 21, 2020 Pending
Array ( [id] => 16686865 [patent_doc_number] => 20210069340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => ANTIFOLATE CONJUGATES FOR TREATING INFLAMMATION [patent_app_type] => utility [patent_app_number] => 16/930590 [patent_app_country] => US [patent_app_date] => 2020-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29763 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16930590 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/930590
ANTIFOLATE CONJUGATES FOR TREATING INFLAMMATION Jul 15, 2020 Abandoned
Array ( [id] => 16398791 [patent_doc_number] => 20200339649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => PEPTIDE ANALOGS [patent_app_type] => utility [patent_app_number] => 16/922850 [patent_app_country] => US [patent_app_date] => 2020-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35619 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16922850 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/922850
Peptide analogs Jul 6, 2020 Issued
Array ( [id] => 18213774 [patent_doc_number] => 20230060040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => USE OF TRANSFERRIN, TRANSFERRIN RECEPTOR AND ANTIBODY THEREOF IN PREPARATION OF ANTI-SARS-CoV-2 DRUG [patent_app_type] => utility [patent_app_number] => 17/415782 [patent_app_country] => US [patent_app_date] => 2020-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3631 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415782 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/415782
USE OF TRANSFERRIN, TRANSFERRIN RECEPTOR AND ANTIBODY THEREOF IN PREPARATION OF ANTI-SARS-CoV-2 DRUG Jun 28, 2020 Pending
Array ( [id] => 16375019 [patent_doc_number] => 20200323861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => ANTIDIABETIC MEDICATIONS [patent_app_type] => utility [patent_app_number] => 16/912764 [patent_app_country] => US [patent_app_date] => 2020-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23860 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 413 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16912764 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/912764
ANTIDIABETIC MEDICATIONS Jun 25, 2020 Abandoned
Array ( [id] => 16360993 [patent_doc_number] => 20200317744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => De Novo Design of Potent and Selective Interleukin Mimetics [patent_app_type] => utility [patent_app_number] => 16/909185 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32113 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909185 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/909185
De novo design of potent and selective interleukin mimetics Jun 22, 2020 Issued
Array ( [id] => 17769385 [patent_doc_number] => 11401313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-02 [patent_title] => De novo design of potent and selective interleukin mimetics [patent_app_type] => utility [patent_app_number] => 16/909210 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 83 [patent_no_of_words] => 31623 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909210 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/909210
De novo design of potent and selective interleukin mimetics Jun 22, 2020 Issued
Array ( [id] => 16398790 [patent_doc_number] => 20200339648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => De Novo Design of Potent and Selective Interleukin Mimetics [patent_app_type] => utility [patent_app_number] => 16/905669 [patent_app_country] => US [patent_app_date] => 2020-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16905669 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/905669
De novo design of potent and selective interleukin mimetics Jun 17, 2020 Issued
Array ( [id] => 18003565 [patent_doc_number] => 20220362331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => ROMO1-DERIVED ANTIMICROBIAL PEPTIDES AND VARIANTS THEREOF [patent_app_type] => utility [patent_app_number] => 17/619913 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11795 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17619913 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/619913
ROMO1-DERIVED ANTIMICROBIAL PEPTIDES AND VARIANTS THEREOF Jun 16, 2020 Pending
Array ( [id] => 18003566 [patent_doc_number] => 20220362332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => ROMO1-DERIVED ANTIMICROBIAL PEPTIDES INCLUDING LYSINE SUBSTITUTION AND VARIANTS THEREOF [patent_app_type] => utility [patent_app_number] => 17/619918 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15550 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17619918 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/619918
ROMO1-DERIVED ANTIMICROBIAL PEPTIDES INCLUDING LYSINE SUBSTITUTION AND VARIANTS THEREOF Jun 16, 2020 Pending
Array ( [id] => 16482488 [patent_doc_number] => 20200376088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK [patent_app_type] => utility [patent_app_number] => 16/903256 [patent_app_country] => US [patent_app_date] => 2020-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22533 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16903256 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/903256
USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK Jun 15, 2020 Abandoned
Array ( [id] => 16673121 [patent_doc_number] => 20210061884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS [patent_app_type] => utility [patent_app_number] => 16/897554 [patent_app_country] => US [patent_app_date] => 2020-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897554 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/897554
SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS Jun 9, 2020 Abandoned
Array ( [id] => 17749614 [patent_doc_number] => 20220227818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => KLEBICINS FOR THE CONTROL OF KLEBSILELLA [patent_app_type] => utility [patent_app_number] => 17/615384 [patent_app_country] => US [patent_app_date] => 2020-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31452 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615384 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/615384
KLEBICINS FOR THE CONTROL OF KLEBSILELLA Jun 4, 2020 Pending
Array ( [id] => 18028937 [patent_doc_number] => 11512110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Targeted delivery system and methods of use therefor [patent_app_type] => utility [patent_app_number] => 16/889137 [patent_app_country] => US [patent_app_date] => 2020-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 53048 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16889137 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/889137
Targeted delivery system and methods of use therefor May 31, 2020 Issued
Array ( [id] => 16482483 [patent_doc_number] => 20200376083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => STABLE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME [patent_app_type] => utility [patent_app_number] => 16/888028 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888028 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/888028
Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same May 28, 2020 Issued
Menu